|Articles|February 1, 2002
Q&A: Derm treatment of NMSC cost-effective
Zoe Diana Draelos, M.D., clinical associate professor of dermatology,Wake Forest School of Medicine, Winston-Salem, N.C., and Phillip Williford,M.D., associate professor of dermatology and director of dermatologic surgery,Wake Forest University School of Medicine, discuss the treatment of nonmelanomaskin cancer by dermatologists and other physician specialties.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows
2
New Phase 3 DISCREET Data Supports Long-Term Use of Apremilast for Genital Psoriasis
3
Phase 3 Results Signal a New Era for Oral Targeted Therapy in Psoriasis
4
Rethinking Aging in Skin of Color: A Pigment-First Approach
5






